Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway

…, SK Kang, SY Han, KL Park, KH Yang, YS Song… - Experimental Cell …, 2004 - Elsevier
Our previous study showed that the peroxisome proliferator-activated receptor-gamma (PPAR-γ)
agonist 15-deoxy-PGJ 2 has the promoting ability to differentiate neuronal PC12 cells. …

Protective role of Bcl-2 on β-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-κB and p38 MAP kinase activation

YS Song, HJ Park, SY Kim, SH Lee, HS Yoo… - Neuroscience …, 2004 - Elsevier
Activation of the apoptosis program by an increased production of beta-amyloid peptides (Aβ)
has been implicated in the neuronal cell death of Alzheimer’s disease (AD). Bcl-2 is a well-…

Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-Δ12, 14-prostaglandin …

…, KS Park, JH Oh, SY Jung, KH Yang, YS Song… - Molecular …, 2003 - ASPET
15-Deoxy-Δ 12,14 -prostaglandin J 2 (15-deoxy-PGJ 2 ), a naturally occurring ligand, activates
the peroxisome proliferator-activated receptor-γ (PPAR-γ). Activation of PPAR-γ has been …

Ryanodine receptor‐mediated interference of neuronal cell differentiation by presenilin 2 mutation

SM Lee, JW Lee, YS Song, DY Hwang… - Journal of …, 2005 - Wiley Online Library
Neuronal cell differentiation alterations induced by mutant presenilin 2 (PS2) were investigated
in transgenic mice expressing wild‐type or mutant‐type PS2. Progressive increases in …

[HTML][HTML] The KMDS-NATION Study: Korean Movement Disorders Society multicenter assessment of non-motor symptoms and quality of life in Parkinson's disease …

…, HK Park, HJ Kim, HW Shin, J Youn… - Journal of clinical …, 2016 - ncbi.nlm.nih.gov
Background and Purpose Nonmotor symptoms (NMS) in Parkinson's disease (PD) have
multisystem origins with heterogeneous manifestations that develop throughout the course of PD…

[HTML][HTML] Weight change is a characteristic non-motor symptom in drug-naive Parkinson's disease patients with non-tremor dominant subtype: a nation-wide …

…, SK Song, YD Kim, JY Yun, HW Lee, IU Song… - PloS one, 2016 - journals.plos.org
Despite the clinical impact of non-motor symptoms (NMS) in Parkinson’s disease (PD), the
characteristic NMS in relation to the motor subtypes of PD is not well elucidated. In this study, …

Internalized stigma and its psychosocial correlates in Korean patients with serious mental illness

WJ Kim, YJ Song, HS Ryu, V Ryu, JM Kim, RY Ha… - Psychiatry …, 2015 - Elsevier
We aimed to examine internalized stigma of patients with mental illness in Korea and identify
the contributing factors to internalized stigma among socio-demographic, clinical, and …

Inhibitory effects of ochratoxin A on nerve growth factor-induced neurite extension through downregulation of p38 MAP kinase and AP-1 activation in cultured …

…, D Joong Kim, T Youl Ha, Y Sook Song… - Journal of Toxicology …, 2004 - Taylor & Francis
Ochratoxin A (OTA) induces microcephaly in animals and in vitro cultured whole embryos.
Inhibition of neuronal cell differentiation was proposed as underlying mechanisms …

[PDF][PDF] Interaction of tetraspan (in) TM4SF5 with CD44 promotes self‐renewal and circulating capacities of hepatocarcinoma cells

…, SH Nam, M Kang, JW Jung, MS Lee, HE Song… - …, 2015 - Wiley Online Library
Tumor metastasis involves circulating and tumor‐initiating capacities of metastatic cancer
cells. Epithelial‐mesenchymal transition (EMT) is related to self‐renewal capacity and …

Protective effect of boldine on dopamine-induced membrane permeability transition in brain mitochondria and viability loss in PC12 cells

YC Youn, OS Kwon, ES Han, JH Song, YK Shin… - Biochemical …, 2002 - Elsevier
Boldine ([S]-2,9-dihydroxy-1,10-dimethoxyaporphine) has been shown to exert antioxidant
and anti-inflammatory effects. The present study elucidated the protective effect of boldine on …